 -- Advances Phase 12 clinical trial of MRT5005 for the treatment of cystic fibrosis CF with resumption of COVID-impacted enrollment and dosing -- -- Presented promising preclinical data at NACFC from next-generation CF program that leverag es advances in mRNA technology -- 